RNAZ
TransCode Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD8.40
-0.33 (-3.78%)
Rating:B-
Company Profile
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$8.13
Prev. Close
$8.73
Day Low
$8.00
Day High
$8.96
52W Low
$3.82
52W High
$20.99
Market Cap
$0.01B
Volume
0.01M